Predictors of adverse events in uncomplicated type B Aortic Dissection: A Systematic Review with Meta-Analysis

• Autor(a) principal: Ana Isabel Bernardes Romeiro
• Data de Publicação: 2021
• Tipo de documento: Dissertação
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://hdl.handle.net/10216/134480
• topic: Medicina clínica; Clinical medicine

INTRODUCTION: Thoracic Endovascular Aortic Repair (TEVAR) has been selectively used for uncomplicated acute type B Aortic Dissection (TBAD); however, not all cases will benefit from TEVAR. A search for high risk clinical and radiographic predictors for complications is ongoing. This systematic review and meta-analysis aimed to identify predictors of major adverse events during follow-up in uncomplicated TBAD, in order to identify who might benefit from elective TEVAR. EVIDENCE ACQUISITION: A systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) statement. EVIDENCE SYNTHESIS: 16 studies were included in a qualitative synthesis and 10 in the meta-analysis. Several risk factors associated to major adverse events have been described, including (1) aortic diameter ≥40 mm, (2) greater false lumen diameter (>22mm), (3) patent false lumen, (4) primary entry tear > 10mm, and (5) greater number of false lumen vessels origin. Quantitative synthesis identified an aortic diameter ≥40 mm significantly associated with major adverse events (HR=3.56; p<0.00001). Reporting of false lumen status, aortic diameters and growth, and demographic data was not always congruent with the most recent recommendations by Society for Vascular Surgery and Society of Thoracic Surgeons, published in 2020. CONCLUSIONS: Acute and subacute TBAD patients with an aortic diameter ≥40 mm should be submitted to expedited TEVAR, as this risk factor had the greatest impact on adverse outcomes (HR). Remaining risk factors have weaker evidence. Additional standards of reporting for some risk factors, long-term outcomes and follow-up imaging are needed for better treatment selection.